Manar El Tabaa

Dr. Manar El Tabaa

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Biochemical Pharmacology
Verified
Journal Article
Closed access
MTManar El Tabaa
Manar El Tabaa
MTMaram Mohammed El Tabaa
Maram Mohammed El Tabaa

1 September 2017 in Neurochemistry International
Verified
Journal Article
Closed access
MTManar El Tabaa
Manar El Tabaa
SSSamia Salem Sokkar
Samia Salem Sokkar
EREhab Sayed Ramadan
Ehab Sayed Ramadan
ISInas Zakria Abd El Salam
Inas Zakria Abd El Salam
AZAnis Anis Mohamed Zaid
Anis Anis Mohamed Zaid

13 September 2023 in Pathology - Research and Practice
Verified
Journal Article
Closed access
MAMai A. Abd-Elmawla
Mai A. Abd-Elmawla
SASherif Sabry abdel-Mageed
Sherif Sabry abdel-Mageed
TATohada M. Al-Noshokaty
Tohada M. Al-Noshokaty
MEMohammed S. Elballal
Mohammed S. Elballal
AAAhmed Ibrahim Abulsoud
Ahmed Ibrahim Abulsoud
Ahmed S. DoghishAhmed S. Doghish
Ahmed S. Doghish

1 July 2022 in International Immunopharmacology
Verified
Journal Article
Open access
MTManar El Tabaa
Manar El Tabaa
MTMaram Mohammed El Tabaa
Maram Mohammed El Tabaa
AZAnis Anis Mohamed Zaid
Anis Anis Mohamed Zaid
RERehab Elgharabawy
Rehab Elgharabawy
NBNermeen El- Borai
Nermeen El- Borai
Cigarette smoking (CS) has been associated with an increased risk of cognitive disorders. Although HMGB1 has been connected to various neurological ailments, its role in the pathogenesis of CS-induced cognitive impairments is undefined. With the ability of GLP-1 to lower HMGB1 expression and improve learning and memory performance, we sought to assess the potential neuroprotective efficacy of Crocin (Cro) as a GLP-1 stimulator against CS-induced cognitive impairments, with a focus on the HMGB1-RAGE/TLR4-NF-κB pathway. Fifty adult rats were specified into: Control; Cro (30 mg/kg); CS; Cro then CS and CS concurrently with Cro. Cognitive functions were assessed by MWM, EMP, and passive avoidance tests. Hippocampal levels of GLP-1, HMGB1, pro-inflammatory cytokines, and apoptotic markers were detected using ELISA, western blotting, and immunohistochemistry. Hippocampal oxidant/antioxidant status was evaluated via colorimetric determination of MDA and TAC. The results revealed that Cro either before or along with CS produced a significant improvement in learning and memory. Cro markedly hindered HMGB1-RAGE/TLR4-NF-κB pathway through enhancing GLP-1 level and expression, which in turn suppressed TNF-α and IL-1β levels and alleviated CS-induced neuroinflammation. Cro significantly counteracted CS-triggered oxidative stress as evidenced by reducing MDA level and raising TAC. Histopathologically, Cro lessened neuronal apoptosis by lowering Bax/Bcl-2 ratio at hippocampal CA2 region. These findings confirmed a GLP-1-dependent neuroprotective action of Cro against CS-induced cognitive disorders via suppressing HMGB1-RAGE/TLR4-NF-κB axis.

4 May 2022 in Expert Opinion on Therapeutic Targets
Verified
Journal Article
Closed access
MTManar El Tabaa
Manar El Tabaa
AFAliaa Mohammed Kamel Fattah
Aliaa Mohammed Kamel Fattah
MSMohamed Shaalan
Mohamed Shaalan
EREman Rashad
Eman Rashad
NMNageh Ahmed El Mahdy
Nageh Ahmed El Mahdy
Asthma is a chronic inflammatory lung disease that universally affects millions of people. Despite numerous well-defined medications, asthma is poorly managed. This study aims to clarify the potent...